Abstract
BackgroundOsteoprotegerin (OPG) may participate in the pathophysiology of rheumatoid arthritis (RA) (1). Recently reported evidence further supports a potential involvement of OPG in endothelial activation and subclinical atherosclerosis in RA...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have